This article is currently undergoing investigation.
Research Paper Volume 12, Issue 19 pp 19585—19596

Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer

class="figure-viewer-img"

Figure 1. Characterization of GPC1-LP (GEM). (A) Size distributions of GPC1-LP (GEM) determined by dynamic light scattering. (B) Cumulative drug release profiling of LP (GEM) and GPC1-LP (GEM) in phosphate-buffer saline (PBS, pH 7.4 and pH 5.0).